Performance status-2 - Symptomatic, 50 in bed - Page 9 of 12 Posts on Medivizor
Navigation Menu

Performance status-2 – Symptomatic, 50 in bed Posts on Medivizor

Robotic radiation treatment compared to radiofrequency ablation for the treatment of liver metastases from colorectal cancer

Robotic radiation treatment compared to radiofrequency ablation for the treatment of liver metastases from colorectal cancer

Posted by on Apr 21, 2013 in Colorectal cancer | 0 comments

In a nutshell This article compares the use of radiofrequency ablation (RFA) and a robotic method of treatment using directed radiation to liver metastases from colorectal cancer which have been deemed not suitable for surgical treatment.  The study shows robotic radiation treatment is safe and comparable to RFA, with a trend towards being better...

Read More

A potential new treatment for triple negative breast cancer: Blocking TGF-beta may improve the outcomes of chemotherapy

A potential new treatment for triple negative breast cancer: Blocking TGF-beta may improve the outcomes of chemotherapy

Posted by on Apr 21, 2013 in Breast cancer | 0 comments

In a nutshell This laboratory based study investigates the use of compounds which block TGF-β signalling in triple negative breast cancer cells.  They show that inhibiting this process prevents the development of paclitaxel resistance and the recurrence of cancers following paclitaxel treatment.  Some background Triple negative...

Read More

Eflornithine and sulindac to prevent recurrence of high risk adenomas and second primary colorectal cancers

Eflornithine and sulindac to prevent recurrence of high risk adenomas and second primary colorectal cancers

Posted by on Apr 19, 2013 in Colorectal cancer | 0 comments

In a nutshell This phase III trial aims to determine the benefits of using the drugs eflornithine and sulindac (Clinoril) in the prevention of high risk adenomas and secondary colorectal cancers. Researchers will look at the number of recurrences over a 3 year period while administering the drugs. The details Patients previously treated for...

Read More

Predicting residual or recurrent disease in patients with invasive colorectal adenocarcinoma developed from colorectal adenoma treated by endoscopy?

Predicting residual or recurrent disease in patients with invasive colorectal adenocarcinoma developed from colorectal adenoma treated by endoscopy?

Posted by on Apr 10, 2013 in Colorectal cancer | 0 comments

In a nutshell The present study evaluated factors associated with residual or recurrent disease in patients with colorectal adenocarcinomas developed from adenomas initially treated endoscopically. Some background A colorectal adenoma is a benign (non-cancerous) abnormal growth in the inner lining of the large intestine (colon and rectum) also...

Read More

Health behaviors in breast cancer survivors to lower the risk for breast cancer

Health behaviors in breast cancer survivors to lower the risk for breast cancer

Posted by on Apr 9, 2013 in Breast cancer | 0 comments

In a nutshell This article evaluates lifestyle behaviors breast cancer survivors adopt in order to lower the risk of recurrence. Some background In the past years the number of breast cancer survivors has increased as a result of early detection and medical advances regarding cancer therapies. However, breast cancer survivors are at great risk of...

Read More

The use of colonoscopic ultrasound in the management of patients with malignant colorectal polyps

The use of colonoscopic ultrasound in the management of patients with malignant colorectal polyps

Posted by on Apr 7, 2013 in Colorectal cancer | 0 comments

In a nutshell The aim of this study was to assess the use of colonoscopic ultrasound in the evaluation of residual disease and local lymph nodes after polypectomy (removal of polyps). The results show that high-frequency ultrasound is beneficial for the assessment of colorectal malignant (cancerous) polyps (abnormal tissue growth). Some background...

Read More

Assessment of lymph node involvement in recurrent breast cancer: results of a nationwide registration study

Assessment of lymph node involvement in recurrent breast cancer: results of a nationwide registration study

Posted by on Apr 7, 2013 in Breast cancer | 0 comments

In a nutshell In patients with recurrent breast cancer, knowledge of regional lymph node involvement serves as an important guide for disease prognosis and treatment decisions. The study presented here investigates the feasibility of “repeat sentinel node biopsy” (SNB) as a prognostic indicator instead of the more invasive “axillary...

Read More

Panitumumab combined with irinotecan as a treatment for metastatic colorecatal cancer without KRAS mutations

Panitumumab combined with irinotecan as a treatment for metastatic colorecatal cancer without KRAS mutations

Posted by on Apr 7, 2013 in Colorectal cancer | 0 comments

In a nutshell This study looks at the use of panitumumab and irinotecan as a combination treatment in patients with KRAS wild-type (non-mutated) metastatic colorectal cancer which has continued to progress while on standard chemotherapy (oxaliplatin, fluoropyrimidines, irinotecan, bevacizumab).   Some background Cancer cells can have...

Read More

A minimally invasive surgical technique called radiofrequency ablation and its use to treat pulmonary metastatic tumours from colorectal cancer

A minimally invasive surgical technique called radiofrequency ablation and its use to treat pulmonary metastatic tumours from colorectal cancer

Posted by on Mar 23, 2013 in Colorectal cancer | 0 comments

In a nutshell This paper looks at a new method of treating pulmonary metastases (spread of colorectal cancer to the lungs). This new treatment is called radiofrequency ablation.  The authors showed that this technique can prevent local tumor progression for extended periods of time and offers good overall survival rates. Some background When...

Read More

Risk of Heart Failure after Anthracycline (Adriamycin/Daunomycin) and Trastuzumab (Herceptin) Treatments for Breast Cancer

Risk of Heart Failure after Anthracycline (Adriamycin/Daunomycin) and Trastuzumab (Herceptin) Treatments for Breast Cancer

Posted by on Mar 19, 2013 in Breast cancer | 0 comments

In a nutshell This study evaluated the risk of heart disease associated with two commonly prescribed treatments for breast cancer. The main finding was that Trastuzumab (Herceptin) and Anthracycline (Adriamycin/Daunomycin) treatments are associated with a higher risk of heart failure or ‘cardiomyopathy’. Some background Anthracyclines...

Read More

The cancer rate among patients who were treated surgically for polyps that were impossible to remove endoscopically

Posted by on Mar 17, 2013 in Colorectal cancer | 0 comments

In a nutshell This study aimed to determine the rate of cancer cases in patients with polyps that were removed surgically. Factors that predict the presence of cancer in these polyps were also investigated. The results confirm the fact that the best therapeutic option for polyps that cannot be removed endoscopically is radical surgery. Some background...

Read More